Which of the following is a potential treatment option for patients with primary immunodeficiency disorders?

Explanation: The correct answer is a. Severe combined immunodeficiency (SCID). SCID is a severe and rare primary immunodeficiency disorder characterized by the absence or severe impairment of both T and B cells, leading to a profound deficiency in cellular and humoral immunity.

Incorrect choices:

b. X-linked agammaglobulinemia (XLA) primarily affects B-cell function, resulting in a lack of mature B cells and low levels of immunoglobulins, but does not typically involve T-cell deficiency.

c. Wiskott-Aldrich syndrome affects platelet function and immune system regulation, but it is not characterized by a deficiency of both T and B cells.

d. Common variable immunodeficiency (CVID) is characterized by reduced levels of immunoglobulins, particularly IgG and IgA, but it does not typically lead to a complete deficiency of both T and B cells.

Explanation: The correct answer is a. Complete blood count (CBC) with differential. A CBC with differential is essential for monitoring the client's immune status and treatment response. It provides information about the client's white blood cell count, including different types of white blood cells, such as lymphocytes, which play a crucial role in the immune response.

Incorrect choices:

b. Blood glucose level is not specifically related to monitoring the immune status or treatment response in clients with immunodeficiency disorders.

c. Liver function tests (LFTs) are important for monitoring liver health but are not directly related to the immune status or treatment response in clients with immunodeficiency disorders.

d. An electrolyte panel is used to assess the balance of electrolytes in the body and is not specifically related to monitoring the immune status or treatment response in clients with immunodeficiency disorders.